tm
Seeing Is Believing
tm
Seeing Is Believing
ReShape Lifesciences's activity chart (see below) currently has 7 price targets and 7 ratings on display.
Analysts average stock forecasts to be materialized ratio is 87.5% with an average time for these price targets to be met of 106.17 days.
Most recent stock forecast was given by ANTHONY VENDETTI from MAXIM GROUP on 17-Jul-2024. First documented stock forecast 31-Oct-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Hold Since 17-Jul-2024
$290000
2 years 1 months 24 days ago
(17-Jul-2024)
2/2 (100%)
$-107297.22 (-27.01%)
35
$126875
$126859.32 (809051.81%)
$337125
4 years 24 days ago
(17-Aug-2022)
1/4 (25%)
$58.89 (0.05%)
13
Hold Since 22-May-2019
$326250
$326234.31 (2080576.00%)
$326250
7 years 3 months 19 days ago
(22-May-2019)
2/2 (100%)
$-673750 (-67.38%)
86
Hold Since 26-Feb-2019
$598125
$598109.31 (3814472.75%)
7 years 6 months 15 days ago
(26-Feb-2019)
1/1 (100%)
$-401875 (-40.19%)
149
Hold Since 03-Jan-2019
$652500
$652484.31 (4161252.00%)
$543750
7 years 6 months 16 days ago
(25-Feb-2019)
2/2 (100%)
$-347500 (-34.75%)
177
What is RSLS (ReShape Lifesciences) average time for price targets to be met?
Which analyst most recently updated their price target on RSLS (ReShape Lifesciences)?
Which analyst has the current lower performing score on RSLS (ReShape Lifesciences) with a proven track record?
Which analyst has the most public recommendations on RSLS (ReShape Lifesciences)?
Which analyst is the currently most bullish on RSLS (ReShape Lifesciences)?
Which analyst is the currently most reserved on RSLS (ReShape Lifesciences)?
